Solid Biosciences Inc (NASDAQ: SLDB) open the trading on Wednesday, with a bit cautious approach as it glided -7.26% to $5.49, before settling in for the price of $5.92 at the close. Taking a more long-term approach, SLDB posted a 52-week range of $2.41-$7.37.
The Healthcare Sector giants’ yearly sales growth during the last 5-year period was 41.25%. Meanwhile, its Annual Earning per share during the time was 41.25%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 34.32%. This publicly-traded company’s shares outstanding now amounts to $77.60 million, simultaneously with a float of $58.32 million. The organization now has a market capitalization sitting at $427.50 million. At the time of writing, stock’s 50-day Moving Average stood at $5.71, while the 200-day Moving Average is $4.74.
Solid Biosciences Inc (SLDB) Ownership Facts and Figures
Sometimes it helps to make our mind if we keep our tabs on how bigger investors are working with the stock of the Biotechnology industry. Solid Biosciences Inc’s current insider ownership accounts for 25.10%, in contrast to 83.88% institutional ownership. According to the most recent insider trade that took place on Oct 20 ’25, this organization’s Chief Medical Officer sold 2,895 shares at the rate of 5.96, making the entire transaction reach 17,254 in total value, affecting insider ownership by 33,819. Preceding that transaction, on Mar 11 ’25, Company’s Director bought 1,860 for 5.34, making the whole transaction’s value amount to 9,924. This particular insider is now the holder of 2,960 in total.
Solid Biosciences Inc (SLDB) Earnings and Revenue Records
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.47 per share during the current fiscal year.
Solid Biosciences Inc’s EPS increase for this current 12-month fiscal period is 34.32% and is forecasted to reach -1.92 in the upcoming year. Considering the longer run, market analysts have predicted that Company’s EPS will increase by 17.67% through the next 5 years, which can be compared against the 41.25% growth it accomplished over the previous five years trading on the market.
Solid Biosciences Inc (NASDAQ: SLDB) Trading Performance Indicators
Let’s observe the current performance indicators for Solid Biosciences Inc (SLDB). It’s Quick Ratio in the last reported quarter now stands at 9.34.
In the same vein, SLDB’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -2.80, a figure that is expected to reach -0.43 in the next quarter, and analysts are predicting that it will be -1.92 at the market close of one year from today.
Technical Analysis of Solid Biosciences Inc (SLDB)
[Solid Biosciences Inc, SLDB] recent stats showed that its last 5-days Average volume was poorer than the volume it posted in the year-ago period. During the previous 9 days, stock’s Stochastic %D was recorded 28.50% While, its Average True Range was 40.33.
Raw Stochastic average of Solid Biosciences Inc (SLDB) in the period of the previous 100 days is set at 37.95%, which indicates a major rise in contrast to 2.80% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 0.39 that was lower than 0.41 volatility it exhibited in the past 100-days period.
